Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 2,364 | 0 | 0 | 0 | 0 |
| Gross Profit | 2,364 | N/A | N/A | N/A | N/A |
| Operating Expenses | 6,835 | 7,787 | 8,534 | 8,926 | 11,654 |
| Operating Income | -4,471 | -7,787 | -8,534 | -8,926 | -11,654 |
| Other Income | 201 | 1 | 1 | 2 | 1 |
| Pre-tax Income | -4,270 | -7,786 | -8,533 | -8,924 | -11,653 |
| Net Income Continuous | -4,270 | -7,786 | -8,533 | -8,924 | -11,653 |
| Net Income | $-4,270 | $-7,786 | $-8,533 | $-8,924 | $-11,653 |
| EPS Basic Total Ops | -0.35 | -0.64 | -0.75 | -0.74 | -0.96 |
| EPS Basic Continuous Ops | -0.35 | -0.64 | -0.70 | -0.74 | -0.96 |
| EPS Diluted Total Ops | -0.35 | -0.64 | -0.75 | -0.74 | -0.96 |
| EPS Diluted Continuous Ops | -0.35 | -0.64 | -0.70 | -0.74 | -0.96 |
| EBITDA(a) | $-4,323 | $-7,527 | $-8,420 | $-8,805 | $-11,518 |